Kanak Bioscience And Research Private Limited - Due diligence report

A 360° intelligence report on Kanak Bioscience And Research: trust score, financial health, credit view, compliance, directors, growth and d…

2011-02-22 Bhubaneswar, Orissa Active Unlisted
Share
Connect MCP
KB Kanak Bioscience And Research Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Kanak Bioscience And Research — 360° Intelligence Report

Generated from MCA filings & public records
72/100
Trust Score
Moderate

Kanak Bioscience And Research is assessed as Moderate with a Trust Score of 72/100. Kanak Bioscience And Research is an active private limited indian non-government company incorporated in 2011, operating in the Metals and Minerals sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 12 Aug 2026 from the latest processed filings. Kanak Bioscience And Research Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
70/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 70/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: MCA.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
DIPAK KUMAR SAHU 01234567 Director 01/04/2018 6 yrs Approved
SANDEEP KUMAR SAHOO 01234567 Director 01/04/2018 6 yrs Approved
BISHNU PRASAD MISHRA 01234567 Director 01/04/2018 6 yrs Approved
MADHUSMITA SAHOO 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • MADHUSMITA SAHOO has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: DIPAK KUMAR SAHU (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Asset base grew 1.42 - capacity expansion.
Operating for 15+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence72/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view71/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 8 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Mar 2022
Director appointed
SANDEEP KUMAR SAHOO (Director)
Director appointed
BISHNU PRASAD MISHRA (Director)
20 Feb 2014
Securities allotted
90000.00 Equity Shares - 9.00 Lakh raised
22 Feb 2011
Incorporated
Registered with Roc Cuttack
Director appointed
DIPAK KUMAR SAHU (Managing Director)
Director appointed
MADHUSMITA SAHOO (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Debt-to-equity stands at 24% - leverage worth monitoring.
Net worth is positive.
4 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sakthi Coffee Estates Private Limited U01131TZ2003PTC010782 Pollachi, Tamil Nadu, India
Thoorpu Kanumula Tribal Farming And Marketing Producer Company Limited U01400AP2019PTC111853 Visakhapatnam, Andhra Pradesh, India
Eeki Foods U01111RJ2018PTC063312 Kota, Rajasthan, India
Haritika Farmer Producer Company Limited U01400UP2020PTC135049 Lalitpur, Uttar Pradesh, India
Rajrappa Kisan Producer Company Limited U01100JH2019PTC012550 Ramgarh, Jharkhand, India
Junagadh Krushi Vasant Producer Company Limited U01100GJ2016PTC093968 Junagadh, Gujarat, India
Sahyadri Balaghat Farmer Producer Company Limited U01100MH2020PTC351703 Dharur, Maharashtra, India
Mor Bio Energy Private Limited U01403HR2012PTC047926 Panipat, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Kanak Bioscience And Research before audits and certifications: compliance score 70/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Kanak Bioscience And Research: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Kanak Bioscience And Research - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Kanak Bioscience And Research pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Kanak Bioscience And Research - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Kanak Bioscience And Research an active company?

Kanak Bioscience And Research has MCA status “Active” with a compliance score of 70/100 (Moderate).

Is Kanak Bioscience And Research financially healthy?

Kanak Bioscience And Research has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.

Should I do business with Kanak Bioscience And Research?

Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Kanak Bioscience And Research?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Kanak Bioscience And Research have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Kanak Bioscience And Research up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 70/100 (Moderate).

Is it risky to lend to Kanak Bioscience And Research?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.